StockData
InfuSystem Holdings, Inc logo

InfuSystem Holdings, Inc (INFU) stock

INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 13/302% above fair value
$14.67−0.12 (-0.81%)

Close on Nov 18, 2026Market cap $292.19MP/E 35.8Yield –

InfuSystem operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

InfuSystem's operating income for the twelve months ending Jun 30, 2026 was $13.27M, up 29.1% year over year. For fiscal 2025 it was $11.92M, up 73.0% from the year before. Over ten years it grew 5.1% a year on average. The highest annual figure on record is $11.92M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.92M+73.0%
FY2024Dec 31, 2024$6.89M+68.6%
FY2023Dec 31, 2023$4.09M+147.2%
FY2022Dec 31, 2022$1.65M-41.3%
FY2021Dec 31, 2021$2.82M-68.1%
FY2020Dec 31, 2020$8.83M+150.4%
FY2019Dec 31, 2019$3.53M+749.4%
FY2018Dec 31, 2018$415.00K–
FY2017Dec 31, 2017-$3.81M-491.4%
FY2016Dec 31, 2016$974.00K-86.6%
FY2015Dec 31, 2015$7.28M-22.0%
FY2014Dec 31, 2014$9.33M+58.3%
FY2013Dec 31, 2013$5.90M+194.8%
FY2012Dec 31, 2012$2.00M–
FY2011Dec 31, 2011-$66.36M–
FY2010Dec 31, 2010-$938.00K-117.6%
FY2009Dec 31, 2009$5.33M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.15M+9.9%
Q1 FY2026Mar 31, 2026$1.59M+157.3%
Q4 FY2025Dec 31, 2025$3.71M+42.0%
Q3 FY2025Sep 30, 2025$3.81M+16.7%
Q2 FY2025Jun 30, 2025$3.78M+103.6%
Q1 FY2025Mar 31, 2025$618.00K–
Q4 FY2024Dec 31, 2024$2.62M+109.3%
Q3 FY2024Sep 30, 2024$3.27M+92.4%
Q2 FY2024Jun 30, 2024$1.86M+48.6%
Q1 FY2024Mar 31, 2024-$845.00K–
Q4 FY2023Dec 31, 2023$1.25M+21.5%
Q3 FY2023Sep 30, 2023$1.70M+80.0%
Q2 FY2023Jun 30, 2023$1.25M+502.9%
Q1 FY2023Mar 31, 2023-$107.00K–
Q4 FY2022Dec 31, 2022$1.03M-35.8%
Q3 FY2022Sep 30, 2022$943.00K–
Q2 FY2022Jun 30, 2022$207.00K-70.3%
Q1 FY2022Mar 31, 2022-$525.00K-160.1%
Q4 FY2021Dec 31, 2021$1.60M+54.8%
Q3 FY2021Sep 30, 2021-$351.00K-110.8%
Q2 FY2021Jun 30, 2021$696.00K-84.6%
Q1 FY2021Mar 31, 2021$873.00K+2545.5%
Q4 FY2020Dec 31, 2020$1.04M-21.1%
Q3 FY2020Sep 30, 2020$3.25M+95.6%
Q2 FY2020Jun 30, 2020$4.51M+364.1%
Q1 FY2020Mar 31, 2020$33.00K–
Q4 FY2019Dec 31, 2019$1.31M+940.5%
Q3 FY2019Sep 30, 2019$1.66M–
Q2 FY2019Jun 30, 2019$971.00K–
Q1 FY2019Mar 31, 2019-$420.00K-171.4%
Q4 FY2018Dec 31, 2018$126.00K–
Q3 FY2018Sep 30, 2018-$95.00K-117.0%
Q2 FY2018Jun 30, 2018-$204.00K–
Q1 FY2018Mar 31, 2018$588.00K–
Q4 FY2017Dec 31, 2017-$1.31M–
Q3 FY2017Sep 30, 2017$560.00K-2.8%
Q2 FY2017Jun 30, 2017-$1.09M–
Q1 FY2017Mar 31, 2017-$1.97M–
Q4 FY2016Dec 31, 2016-$454.00K–
Q3 FY2016Sep 30, 2016$576.00K–

More InfuSystem figures

See a number that looks wrong?